AbCellera Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 8731 https://www.abcellera.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc

AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners may be pleased with recent gains after 43% loss over the past year - Oct 3rd, 2022 10:45 am
AbCellera Launches Second Phase of Global Headquarters Expansion to Advance Capabilities for Bringing New Medicines from Target to the Clinic - Sep 21st, 2022 12:00 pm
CEO, President & Chairperson Carl Hansen Just Bought A Handful Of Shares In AbCellera Biologics Inc. (NASDAQ:ABCL) - Aug 24th, 2022 10:15 am
Implied Volatility Surging for AbCellera (ABCL) Stock Options - Aug 18th, 2022 12:50 pm
Why AbCellera Biologics Rallied as Much as 24% on Wednesday - Aug 10th, 2022 5:20 pm
AbCellera Biologics Inc. (ABCL) Q2 2022 Earnings Call Transcript - Aug 10th, 2022 4:30 am
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates - Aug 9th, 2022 10:05 pm
AbCellera Reports Q2 2022 Business Results - Aug 9th, 2022 8:05 pm
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: Should You Buy? - Aug 4th, 2022 2:00 pm
AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients - Aug 3rd, 2022 11:00 am
AbCellera Biologics Inc. (ABCL) Earnings Expected to Grow: Should You Buy? - Aug 2nd, 2022 2:00 pm
Abcellera Biologics Stock Sees Relative Strength Rating Jump To 89 - Jul 27th, 2022 3:15 pm
Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - Jul 27th, 2022 11:00 am
AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022 - Jul 12th, 2022 8:05 pm
Is AbCellera Biologics Inc.'s (NASDAQ:ABCL) Recent Stock Performance Tethered To Its Strong Fundamentals? - Jul 11th, 2022 2:14 pm
Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options - Jun 29th, 2022 3:04 pm
Insiders rewarded with a US$7.1m addition on top of their US$20m purchase as AbCellera Biologics Inc. (NASDAQ:ABCL) hits US$2.9b - Jun 23rd, 2022 12:52 pm
AbCellera Biologics Inc. (ABCL) Stock Jumps 9.3%: Will It Continue to Soar? - Jun 20th, 2022 12:53 pm
AbCellera Biologics (NASDAQ:ABCL) stock falls 4.6% in past week as one-year earnings and shareholder returns continue downward trend - Jun 5th, 2022 12:21 pm
Masayoshi Son is Selling These 9 Stocks in 2022 - May 25th, 2022 7:00 pm